Market
What will be the international reaction to Russia's EnteroMix launch by mid-2025?
2
Resolution / Starting Odds
Positive • 25%
Neutral • 25%
Negative • 25%
Mixed • 25%
Coverage in international news outlets such as BBC, CNN, or Reuters
Story
Russia to Launch Free mRNA Cancer Vaccine in 2025 with 75-80% Tumor Reduction
Dec 17, 2024, 10:01 PM
Russia has announced the development of a cancer vaccine that will be distributed free of charge to cancer patients starting in early 2025. The vaccine, developed by the Ministry of Health in collaboration with the Engelhardt Institute of Molecular Biology and the Gamaleya National Research Center, is reportedly a personalized mRNA-based treatment designed to slow tumor progression and reduce tumor size by up to 75-80%. According to Andrey Kaprin, Chief Oncologist of the Ministry of Health, the vaccine will be offered to patients who have exhausted other treatment options. The clinical trials for the vaccine, named 'EnteroMix,' are set to begin soon, with candidates being selected from patients aged 18 to 75 who have histologically confirmed tumors. The vaccine is not intended for prevention in the general population but will be tailored to treat individual cancer patients. The cost of production is estimated at 300,000 rubles per dose, but it will be provided free to Russian citizens. It remains unclear which specific types of cancer the vaccine is designed to treat.
View original story
Similar markets
Positive • 25%
Mixed • 25%
Negative • 25%
Neutral • 25%
More than 20 billion rubles • 25%
10 to 20 billion rubles • 25%
5 to 10 billion rubles • 25%
Less than 5 billion rubles • 25%
More than 100,000 doses • 25%
10,000 to 50,000 doses • 25%
50,001 to 100,000 doses • 25%
Less than 10,000 doses • 25%
China • 25%
Other • 25%
Brazil • 25%
India • 25%
None • 25%
More than 10 countries • 25%
6 to 10 countries • 25%
1 to 5 countries • 25%
Successful with expected results • 25%
Results inconclusive • 25%
Partially successful • 25%
Unsuccessful • 25%
Economic sanctions • 25%
Other • 25%
Condemnation without action • 25%
Military support to Ukraine • 25%
Formal condemnations without further action • 25%
Mediation efforts initiated • 25%
No significant international response • 25%
Increased sanctions on Russia • 25%
EU Approval • 25%
U.S. FDA Approval • 25%
WHO Recognition • 25%
No International Recognition • 25%